PRISCA OGBONNAYA: Open Payments
NPI 1164140083 · UNION, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$417 in 16 payments from 6 companies in 2025. Trend: 2023 $13 · 2024 $75 · 2025 $417
Food & beverage: $417
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 5 | $152 |
| Otsuka America Pharmaceutical, Inc. | 3 | $86 |
| Janssen Pharmaceuticals, Inc | 1 | $56 |
| ABBVIE INC. | 3 | $53 |
| Teva Pharmaceuticals USA, Inc. | 3 | $48 |
| Gilead Sciences, Inc. | 1 | $23 |
Products named: ARISTADA, LYBALVI, REXULTI, INVEGA SUSTENNA, VRAYLAR, UZEDY, ABILIFY ASIMTUFII.
Industry payments across NJ — which companies pay providers there.
